PureTech Health Financials

PRTC Stock

USD 18.67 0.39 2.05%

PureTech Health PLC may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. At present, PureTech Health's Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 8 M, whereas Total Assets are forecasted to decline to about 554 M.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Interest Hikes

PureTech Health Balance Sheet Chart

At present, PureTech Health's Property Plant And Equipment Net is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 8 M, whereas Total Assets are forecasted to decline to about 554 M.

Total Assets Short Long Term Debt Total Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Key indicators impacting PureTech Health's financial strength include:

Current Value

Last Year

Change From Last Year

10 Year Trend

Current Ratio

8.82

8.4

Sufficiently Up

Slightly volatile

The essential information of the day-to-day investment outlook for PureTech Health includes many different criteria found on its balance sheet. An individual investor should monitor PureTech Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in PureTech Health.

Net Income

64.61 Million

Build AI portfolio with PureTech Stock

Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.

PureTech Health Stock Summary

PureTech Health competes with Autolus Therapeutics, Neurogene, Solid Biosciences, QuantumSi, and Lineage Cell. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.

Foreign Associate	UK
Specialization	Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Instrument	USA Stock View All
Exchange	NASDAQ Exchange
ISIN	US7462371060
Business Address	6 Tide Street,
Sector	Biotechnology
Industry	Health Care
Benchmark	Dow Jones Industrial
Website	www.puretechhealth.com
Phone	617 482 2333
Currency	USD - US Dollar

PureTech Health Key Financial Ratios

	Return On Equity	0.0944
	Profit Margin	7.93 %
	Operating Margin	(25.90) %
	Price To Sales	70.60 X
	Revenue	4.83 M

More Fundamentals

PureTech Health Key Balance Sheet Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	946.0M	702.6M	694.0M	602.6M	693.0M	554.0M
Other Current Liab	174.0M	55.7M	59.1M	28.1M	32.3M	30.7M
Net Debt	(413.7M)	(103.0M)	(165.7M)	(258.3M)	(232.5M)	(244.1M)
Retained Earnings	199.9M	149.5M	83.8M	32.5M	37.4M	23.4M
Accounts Payable	11.3M	26.5M	14.6M	5.5M	6.4M	8.0M
Cash	465.7M	149.9M	191.1M	280.6M	322.7M	190.2M
Net Receivables	3.6M	22.4M	2.4M	12.9M	14.8M	15.6M
Other Current Assets	4.5M	13.7M	17.7M	6.0M	7.0M	7.0M
Total Liab	361.9M	155.1M	235.7M	194.7M	223.9M	223.0M
Total Current Assets	501.8M	386.2M	347.2M	386.3M	444.2M	297.7M
Short Term Debt	9.4M	12.5M	7.1M	7.7M	8.8M	9.3M
Intangible Assets	987K	831K	906K	601K	540.9K	513.9K
Common Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.2M
Other Liab	116.7M	108.6M	92.4M	23.8M	27.3M	26.0M
Net Tangible Assets	667.4M	668.8M	592.5M	541.4M	622.6M	490.8M
Other Assets	2.3M	1K	2.1M	1.0	0.9	0.86
Short Long Term Debt	4.8M	7.5M	3.7M	4.1M	3.7M	6.6M
Net Invested Capital	612.5M	560.0M	467.8M	418.8M	481.6M	543.0M
Net Working Capital	275.7M	289.3M	295.8M	344.9M	396.6M	416.4M
Capital Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.3M

PureTech Health Key Income Statement Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Interest Expense	4.7M	4.0M	13.5M	10.0M	11.5M	6.7M
Total Revenue	10.0M	2.1M	3.3M	4.8M	4.3M	5.4M
Gross Profit	(100.5M)	(136.8M)	(1.6M)	1.3M	1.1M	1.2M
Operating Income	(150.3M)	(197.8M)	(146.2M)	(136.1M)	(122.5M)	(128.6M)
Ebit	19.5M	(197.8M)	(16.6M)	33.8M	38.9M	40.8M
Research Development	81.5M	116.1M	96.2M	54.3M	62.4M	56.5M
Ebitda	26.7M	(188.9M)	(11.6M)	37.4M	43.0M	45.1M
Income Before Tax	(59.0M)	(92.8M)	(36.1M)	23.8M	27.3M	28.7M
Net Income	(60.6M)	(50.4M)	(65.7M)	53.5M	61.5M	64.6M
Income Tax Expense	3.8M	(55.7M)	30.5M	(4.0M)	(4.6M)	(4.4M)
Tax Provision	3.8M	(55.7M)	30.5M	(4.0M)	(3.6M)	(3.4M)
Net Interest Income	(4.5M)	1.8M	2.5M	12.6M	14.5M	15.3M
Interest Income	214K	5.8M	16.0M	22.7M	26.1M	27.4M
Minority Interest	2.2M	(13.3M)	931K	25.7M	29.6M	31.1M

PureTech Health Key Cash Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Change In Cash	61.8M	(315.8M)	41.2M	89.6M	80.6M	84.6M
Free Cash Flow	(163.9M)	(181.0M)	(106.2M)	(134.4M)	(120.9M)	(127.0M)
Depreciation	7.3M	8.9M	4.9M	3.6M	4.1M	3.9M
Other Non Cash Items	(5.1M)	(111.1M)	(67.1M)	(178.3M)	(160.5M)	(152.5M)
Capital Expenditures	5.7M	2.2M	245K	11K	12.7K	12.0K
Net Income	(62.7M)	(37.1M)	(65.7M)	27.8M	31.9M	33.5M
End Period Cash Flow	465.7M	149.9M	191.1M	280.6M	322.7M	176.9M
Investments	217.6M	(107.2M)	69.0M	240.9M	277.0M	290.9M

PureTech Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PureTech Health competition to find correlations between indicators driving PureTech Health's intrinsic value. More Info.

PureTech Health PLC is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . At present, PureTech Health's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.

Most indicators from PureTech Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into PureTech Health PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PureTech Health PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

At present, PureTech Health's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 6.05, whereas Selling General Administrative is forecasted to decline to about 27.2 M.

	2023	2024	2025	2026 (projected)
Interest Expense	13.5M	10.0M	11.5M	6.7M
Depreciation And Amortization	4.9M	3.6M	4.1M	3.9M

Interest Expense Depreciation And Amortization

PureTech Health fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Total Assets		0.9	0.3	0.36	0.99	0.93	0.02	-0.75	0.77	0.69	0.81	0.91	0.62	0.81	0.39	-0.14	0.9	0.14	0.81	0.51	0.57	0.97	0.87	0.91	0.81	0.36
Short Long Term Debt Total	0.9		0.08	0.26	0.9	0.94	0.13	-0.71	0.87	0.69	0.78	0.85	0.83	0.67	0.38	-0.14	0.7	-0.07	0.69	0.58	0.44	0.87	0.7	0.9	0.68	0.52
Other Current Liab	0.3	0.08		0.82	0.25	0.22	0.2	-0.13	-0.16	0.15	0.13	0.23	0.24	0.3	-0.18	-0.17	0.49	0.36	-0.07	0.32	0.24	0.41	0.61	0.19	0.3	-0.32
Total Current Liabilities	0.36	0.26	0.82		0.32	0.28	0.7	-0.24	-0.1	0.07	0.25	0.26	0.5	0.4	-0.27	-0.03	0.49	0.33	-0.13	0.3	0.2	0.46	0.71	0.16	0.39	-0.52
Total Stockholder Equity	0.99	0.9	0.25	0.32		0.93	0.0	-0.72	0.78	0.73	0.78	0.91	0.59	0.79	0.44	-0.11	0.88	0.16	0.8	0.45	0.58	0.97	0.83	0.92	0.8	0.37
Property Plant And Equipment Net	0.93	0.94	0.22	0.28	0.93		0.02	-0.62	0.89	0.76	0.69	0.93	0.72	0.62	0.38	-0.2	0.74	-0.02	0.7	0.59	0.43	0.92	0.73	0.95	0.63	0.48
Current Deferred Revenue	0.02	0.13	0.2	0.7	0.0	0.02		-0.03	-0.14	-0.24	0.06	-0.01	0.44	0.07	-0.49	0.19	0.01	0.04	-0.39	0.07	-0.13	0.06	0.29	-0.17	0.05	-0.61
Net Debt	-0.75	-0.71	-0.13	-0.24	-0.72	-0.62	-0.03		-0.53	-0.33	-0.98	-0.53	-0.57	-0.84	-0.32	-0.18	-0.6	0.1	-0.7	-0.69	-0.27	-0.66	-0.69	-0.66	-0.84	-0.29
Retained Earnings	0.77	0.87	-0.16	-0.1	0.78	0.89	-0.14	-0.53		0.65	0.6	0.86	0.59	0.37	0.32	-0.15	0.45	-0.34	0.71	0.53	0.25	0.69	0.43	0.85	0.39	0.69
Accounts Payable	0.69	0.69	0.15	0.07	0.73	0.76	-0.24	-0.33	0.65		0.39	0.63	0.48	0.53	0.64	-0.16	0.63	0.35	0.51	0.26	0.75	0.74	0.42	0.85	0.56	0.41
Cash	0.81	0.78	0.13	0.25	0.78	0.69	0.06	-0.98	0.6	0.39		0.59	0.63	0.86	0.33	0.13	0.65	-0.1	0.71	0.69	0.3	0.71	0.71	0.72	0.86	0.33
Non Current Assets Total	0.91	0.85	0.23	0.26	0.91	0.93	-0.01	-0.53	0.86	0.63	0.59		0.55	0.49	0.24	-0.2	0.73	-0.09	0.75	0.41	0.41	0.87	0.75	0.84	0.5	0.46
Non Currrent Assets Other	0.62	0.83	0.24	0.5	0.59	0.72	0.44	-0.57	0.59	0.48	0.63	0.55		0.51	0.12	-0.12	0.45	-0.13	0.25	0.67	0.26	0.64	0.58	0.64	0.51	0.28
Cash And Short Term Investments	0.81	0.67	0.3	0.4	0.79	0.62	0.07	-0.84	0.37	0.53	0.86	0.49	0.51		0.47	0.01	0.84	0.42	0.63	0.47	0.6	0.79	0.77	0.7	1.0	0.09
Net Receivables	0.39	0.38	-0.18	-0.27	0.44	0.38	-0.49	-0.32	0.32	0.64	0.33	0.24	0.12	0.47		-0.11	0.45	0.33	0.49	-0.03	0.44	0.44	0.13	0.56	0.49	0.39
Common Stock Total Equity	-0.14	-0.14	-0.17	-0.03	-0.11	-0.2	0.19	-0.18	-0.15	-0.16	0.13	-0.2	-0.12	0.01	-0.11		-0.29	-0.22	-0.2	-0.1	-0.19	-0.2	-0.17	-0.21	-0.01	-0.28
Common Stock Shares Outstanding	0.9	0.7	0.49	0.49	0.88	0.74	0.01	-0.6	0.45	0.63	0.65	0.73	0.45	0.84	0.45	-0.29		0.48	0.7	0.29	0.71	0.92	0.9	0.77	0.84	0.14
Short Term Investments	0.14	-0.07	0.36	0.33	0.16	-0.02	0.04	0.1	-0.34	0.35	-0.1	-0.09	-0.13	0.42	0.33	-0.22	0.48		-0.02	-0.32	0.63	0.27	0.25	0.09	0.42	-0.41
Non Current Liabilities Total	0.81	0.69	-0.07	-0.13	0.8	0.7	-0.39	-0.7	0.71	0.51	0.71	0.75	0.25	0.63	0.49	-0.2	0.7	-0.02		0.34	0.5	0.69	0.61	0.75	0.64	0.58
Inventory	0.51	0.58	0.32	0.3	0.45	0.59	0.07	-0.69	0.53	0.26	0.69	0.41	0.67	0.47	-0.03	-0.1	0.29	-0.32	0.34		-0.02	0.45	0.49	0.58	0.48	0.31
Other Current Assets	0.57	0.44	0.24	0.2	0.58	0.43	-0.13	-0.27	0.25	0.75	0.3	0.41	0.26	0.6	0.44	-0.19	0.71	0.63	0.5	-0.02		0.58	0.51	0.55	0.61	0.1
Other Stockholder Equity	0.97	0.87	0.41	0.46	0.97	0.92	0.06	-0.66	0.69	0.74	0.71	0.87	0.64	0.79	0.44	-0.2	0.92	0.27	0.69	0.45	0.58		0.86	0.9	0.79	0.31
Total Liab	0.87	0.7	0.61	0.71	0.83	0.73	0.29	-0.69	0.43	0.42	0.71	0.75	0.58	0.77	0.13	-0.17	0.9	0.25	0.61	0.49	0.51	0.86		0.67	0.77	0.0
Property Plant And Equipment Gross	0.91	0.9	0.19	0.16	0.92	0.95	-0.17	-0.66	0.85	0.85	0.72	0.84	0.64	0.7	0.56	-0.21	0.77	0.09	0.75	0.58	0.55	0.9	0.67		0.73	0.52
Total Current Assets	0.81	0.68	0.3	0.39	0.8	0.63	0.05	-0.84	0.39	0.56	0.86	0.5	0.51	1.0	0.49	-0.01	0.84	0.42	0.64	0.48	0.61	0.79	0.77	0.73		0.11
Short Term Debt	0.36	0.52	-0.32	-0.52	0.37	0.48	-0.61	-0.29	0.69	0.41	0.33	0.46	0.28	0.09	0.39	-0.28	0.14	-0.41	0.58	0.31	0.1	0.31	0.0	0.52	0.11

Click cells to compare fundamentals

PureTech Health Account Relationship Matchups

PureTech Health fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	946.0M	702.6M	694.0M	602.6M	693.0M	554.0M
Other Current Liab	174.0M	55.7M	59.1M	28.1M	32.3M	30.7M
Net Debt	(413.7M)	(103.0M)	(165.7M)	(258.3M)	(232.5M)	(244.1M)
Retained Earnings	199.9M	149.5M	83.8M	32.5M	37.4M	23.4M
Accounts Payable	11.3M	26.5M	14.6M	5.5M	6.4M	8.0M
Cash	465.7M	149.9M	191.1M	280.6M	322.7M	190.2M
Net Receivables	3.6M	22.4M	2.4M	12.9M	14.8M	15.6M
Other Current Assets	4.5M	13.7M	17.7M	6.0M	7.0M	7.0M
Total Liab	361.9M	155.1M	235.7M	194.7M	223.9M	223.0M
Total Current Assets	501.8M	386.2M	347.2M	386.3M	444.2M	297.7M
Short Term Debt	9.4M	12.5M	7.1M	7.7M	8.8M	9.3M
Intangible Assets	987K	831K	906K	601K	540.9K	513.9K
Common Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.2M
Other Liab	116.7M	108.6M	92.4M	23.8M	27.3M	26.0M
Net Tangible Assets	667.4M	668.8M	592.5M	541.4M	622.6M	490.8M
Other Assets	2.3M	1K	2.1M	1.0	0.9	0.86
Short Long Term Debt	4.8M	7.5M	3.7M	4.1M	3.7M	6.6M
Net Invested Capital	612.5M	560.0M	467.8M	418.8M	481.6M	543.0M
Net Working Capital	275.7M	289.3M	295.8M	344.9M	396.6M	416.4M
Capital Stock	5.4M	5.5M	5.5M	4.9M	4.4M	4.3M

Today, most investors in PureTech Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PureTech Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of PureTech Health growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.0613)

At present, PureTech Health's Price Earnings To Growth Ratio is projected to slightly decrease based on the last few years of reporting.

PureTech Health January 29, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of PureTech Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of PureTech Health PLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of PureTech Health PLC based on widely used predictive technical indicators. In general, we focus on analyzing PureTech Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build PureTech Health's daily price indicators and compare them against related drivers.

	Downside Deviation	3.62
	Information Ratio	0.0111
	Maximum Drawdown	14.71
	Value At Risk	(5.57)
	Potential Upside	4.81

Complementary Tools for PureTech Stock analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Transaction History View history of all your transactions and understand their impact on performance
	Commodity Directory Find actively traded commodities issued by global exchanges
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

PureTech Health Financials

PureTech Health Balance Sheet Chart

Net Income

64.61 Million

PureTech Health Stock Summary

PureTech Health Key Financial Ratios

PureTech Health Key Balance Sheet Accounts

PureTech Health Key Income Statement Accounts

PureTech Health Key Cash Accounts

PureTech Financial Ratios Relationships

PureTech Health fundamental ratios Correlations

PureTech Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PureTech Health fundamental ratios Accounts

Price Earnings To Growth Ratio

(0.0613)

PureTech Health January 29, 2026 Opportunity Range

Complementary Tools for PureTech Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.97	Total Assets
Other Stockholder Equity	+ 0.97	Total Stockholder Equity
Property Plant And Equipment Gross	+ 0.95	Property Plant And Equipment Net
Property Plant And Equipment Net	+ 0.94	Short Long Term Debt Total

Cash	- 0.98	Net Debt
Total Current Assets	- 0.84	Net Debt
Cash And Short Term Investments	- 0.84	Net Debt
Net Debt	- 0.75	Total Assets
Net Debt	- 0.72	Total Stockholder Equity
Net Debt	- 0.71	Short Long Term Debt Total